חזרה לתוצאות החיפוש

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Diffuse Cutaneous Systemic Sclerosis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Arizona Arthritis and Rheumatology Research PLLC, Mesa, Arizona, United States

    Contact: Study coordinator (Debra Mc Dermed) · Debra.McDermed@azarthritis.com · +1 602 386 4970
    Contact: Principal Investigator (Nehad Soloman)

  • UCLA, Los Angeles, California, United States

    Contact: Study coordinator (Lauren Nam) · lnam@mednet.ucla.edu · +1 310 488 0162
    Contact: Principal Investigator (Suzanne Kafaja)

  • Hoag Hospital, Newport Beach, California, United States

    Contact: Study coordinator (Vicki Tan) · vicki.tan@hoag.org · +1 949 791 3049
    Contact: Principal Investigator (Christine Thai)

  • Clinical Res Of W Florida, Clearwater, Florida, United States

    Contact: Study coordinator (Amber Tipker) · atipker@crwf.com · +1 727 466 0078
    Contact: Principal Investigator (Rodney Daniel)

  • GNP Research, Cooper City, Florida, United States

    Contact: Study coordinator (Melissa Pierce) · melissa@gnpresearch.com · +1 754 248 3589
    Contact: Principal Investigator (Mark Jaffe)

  • IRIS Research and Development, Plantation, Florida, United States

    Contact: Study coordinator (Jhon Galindo) · jgalindo@irisrheumatology.com · +1 954 476 2338
    Contact: Principal Investigator (Guillermo Valenzuela)

  • Sarasota Arthritis Res Ctr, Sarasota, Florida, United States

    Contact: Study coordinator (Carole Kringel) · carole@arthritiscenters.net · +1 941 365 0770
    Contact: Principal Investigator (Jaishree Manohar)

  • University of Chicago Hospitals, Chicago, Illinois, United States

    Contact: Study coordinator (J Heannhehbelle Rosier) · jrosier@uchicagomedicine.org · +1 773 702 3853
    Contact: Principal Investigator (Michael Macklin)

  • UMC New Orleans, New Orleans, Louisiana, United States

    Contact: Study coordinator (Sean Barry) · sbarr2@lsuhsc.edu
    Contact: Principal Investigator (Stephen Lindsey)

  • Uni Of Michigan Health System, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Christopher Floyd) · cjfloyd@med.umich.edu · +1 734 936 5504
    Contact: Principal Investigator (Carleigh Zahn)

  • Wayne State University, Detroit, Michigan, United States

    Contact: Study coordinator (Biljana Basic-Panic) · bbasicpanic@med.wayne.edu
    Contact: Principal Investigator (Ilyes Benchaala)

  • Clinical Research Inst of MI, Saint Clair Shores, Michigan, United States

    Contact: Study coordinator (Amelia Paliewicz) · apaliewicz@researchmi.com · +1 586 777 7577
    Contact: Principal Investigator (Andrew Sulich)

  • Hospital for Special Surgery, New York, New York, United States

    Contact: Study coordinator (Liza Morales) · moralesli@HSS.EDU · +1 212 774 2596
    Contact: Principal Investigator (Kimberly Showalter Lakin)

  • West Tennessee Research Institute, Jackson, Tennessee, United States

    Contact: Study coordinator (Sherry Wiggins) · swiggins@arthritisclinic.org · 17316330119
    Contact: Principal Investigator (Jacob A Aelion)

  • Arthritis and Rheumatology Ins, Allen, Texas, United States

    Contact: Study coordinator (Samina Shehzad) · shehzad.s@dfwarthritis.com
    Contact: Principal Investigator (Megha Patel Banker)

  • Novel Research LLC, Bellaire, Texas, United States

    Contact: Study coordinator (Hassan Khan) · khan@novelresearch.net
    Contact: Principal Investigator (Wajeeha Yousaf)

  • Prolato Clinical Research Center, Houston, Texas, United States

    Contact: Study coordinator (Mohammad Alsayed) · malsayed@prolato.org · +1 832 338 9118
    Contact: Principal Investigator (Michelle Eisenberg)

  • Novartis Investigative Site, CABA, Buenos Aires, Argentina

  • Novartis Investigative Site, CABA, Buenos Aires, Argentina

  • Novartis Investigative Site, Caba, Argentina

  • Novartis Investigative Site, Caba, Argentina

  • Novartis Investigative Site, San Miguel de Tucumán, Argentina

  • Novartis Investigative Site, Graz, Austria

  • Novartis Investigative Site, Leuven, Belgium

  • Novartis Investigative Site, Salvador, Estado de Bahia, Brazil

  • Novartis Investigative Site, Curitiba, Paraná, Brazil

  • Novartis Investigative Site, Porto Alegre, Rio Grande do Sul, Brazil

  • Novartis Investigative Site, Sao Jose Rio Preto, São Paulo, Brazil

  • Novartis Investigative Site, São Paulo, São Paulo, Brazil

  • Novartis Investigative Site, São Paulo, São Paulo, Brazil

  • Novartis Investigative Site, Nanning, Guangxi, China

  • Novartis Investigative Site, Zhengzhou, Henan, China

  • Novartis Investigative Site, Changchun, Jilin, China

  • Novartis Investigative Site, Chengdu, Sichuan, China

  • Novartis Investigative Site, Ningbo, Zhejiang, China

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Tianjin, China

  • Novartis Investigative Site, Medellín, Antioquia, Colombia

  • Novartis Investigative Site, Bogota, Cundinamarca, Colombia

  • Novartis Investigative Site, Bogota, Cundinamarca, Colombia

  • Novartis Investigative Site, Cali, Valle del Cauca Department, Colombia

  • Novartis Investigative Site, Bogotá, Colombia

  • Novartis Investigative Site, Medellín, Colombia

  • Novartis Investigative Site, Dijon, France

  • Novartis Investigative Site, Le Mans, France

  • Novartis Investigative Site, Lille, France

  • Novartis Investigative Site, Montpellier, France

  • Novartis Investigative Site, Paris, France

  • Novartis Investigative Site, Rennes, France

  • Novartis Investigative Site, Strasbourg, France

  • Novartis Investigative Site, Toulouse, France

  • Novartis Investigative Site, Würzburg, Bavaria, Germany

  • Novartis Investigative Site, Jena, Thuringia, Germany

  • Novartis Investigative Site, Berlin, Germany

  • Novartis Investigative Site, Alexandroupoli, Greece

  • Novartis Investigative Site, Athens, Greece

  • Novartis Investigative Site, Athens, Greece

  • Novartis Investigative Site, Pécs, Baranya, Hungary

  • Novartis Investigative Site, Debrecen, Hajdu Bihar Megye, Hungary

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Kochi, Kerala, India

  • Novartis Investigative Site, Mumbai, Maharashtra, India

  • Novartis Investigative Site, Mumbai, Maharashtra, India

  • Novartis Investigative Site, New Delhi, National Capital Territory of Delhi, India

  • Novartis Investigative Site, New Delhi, New Delhi, India

  • Novartis Investigative Site, Jaipur, Rajasthan, India

  • Novartis Investigative Site, Ancona, AN, Italy

  • Novartis Investigative Site, Milan, MI, Italy

  • Novartis Investigative Site, Rozzano, MI, Italy

  • Novartis Investigative Site, Modena, MO, Italy

  • Novartis Investigative Site, Palermo, PA, Italy

  • Novartis Investigative Site, Pavia, PV, Italy

  • Novartis Investigative Site, Roma, RM, Italy

  • Novartis Investigative Site, Verona, VR, Italy

  • Novartis Investigative Site, Nagoya, Aichi-ken, Japan

  • Novartis Investigative Site, Toyoake, Aichi-ken, Japan

  • Novartis Investigative Site, Kitakyushu, Fukuoka, Japan

  • Novartis Investigative Site, Maebashi, Gunma, Japan

  • Novartis Investigative Site, Sapporo, Hokkaido, Japan

  • Novartis Investigative Site, Sapporo, Hokkaido, Japan

  • Novartis Investigative Site, Yokohama, Kanagawa, Japan

  • Novartis Investigative Site, Suita, Osaka, Japan

  • Novartis Investigative Site, Iruma-gun, Saitama, Japan

  • Novartis Investigative Site, Bunkyo-ku, Tokyo, Japan

  • Novartis Investigative Site, Chuo Ku, Tokyo, Japan

  • Novartis Investigative Site, Shinjuku Ku, Tokyo, Japan

  • Novartis Investigative Site, Shinjuku-ku, Tokyo, Japan

  • Novartis Investigative Site, Toyama, Toyama, Japan

  • Novartis Investigative Site, Fukuoka, Japan

  • Novartis Investigative Site, Hiroshima, Japan

  • Novartis Investigative Site, Ishikawa, Japan

  • Novartis Investigative Site, Kyoto, Japan

  • Novartis Investigative Site, Cheras, Kuala Lumpur, Malaysia

  • Novartis Investigative Site, Kuala Lumpur, Malaysia

  • Novartis Investigative Site, Chihuahua City, Chihuahua, Mexico

  • Novartis Investigative Site, Guadalajara, Jalisco, Mexico

  • Novartis Investigative Site, Mexico City, Mexico City, Mexico

  • Novartis Investigative Site, Mexico City, Mexico City, Mexico

  • Novartis Investigative Site, Monterrey, Nuevo León, Mexico

  • Novartis Investigative Site, Bydgoszcz, Poland

  • Novartis Investigative Site, Warsaw, Poland

  • Novartis Investigative Site, Coimbra, Portugal

  • Novartis Investigative Site, Lisbon, Portugal

  • Novartis Investigative Site, Vila Nova de Gaia, Portugal

  • Novartis Investigative Site, Seoul, Seoul, South Korea

  • Novartis Investigative Site, Busan, South Korea

  • Novartis Investigative Site, Seoul, South Korea

  • Novartis Investigative Site, Seoul, South Korea

  • Novartis Investigative Site, Málaga, Andalusia, Spain

  • Novartis Investigative Site, Valencia, Valencia, Spain

  • Novartis Investigative Site, Barcelona, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Salamanca, Spain

  • Novartis Investigative Site, Changhua, Taiwan

  • Novartis Investigative Site, Kaohsiung City, Taiwan

  • Novartis Investigative Site, Taichung, Taiwan

  • Novartis Investigative Site, Taoyuan, Taiwan

  • Novartis Investigative Site, Khon Kaen, THA, Thailand

  • Novartis Investigative Site, Bangkok, Thailand

  • Novartis Investigative Site, Istanbul, Fatih, Turkey (Türkiye)

  • Novartis Investigative Site, Ankara, Sihhiye-Altindag, Turkey (Türkiye)

  • Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)

  • Novartis Investigative Site, Basingstoke, Hampshire, United Kingdom

  • Novartis Investigative Site, Bristol, United Kingdom

  • Novartis Investigative Site, London, United Kingdom

  • Novartis Investigative Site, Ho Chi Minh City, VNM, Vietnam

  • Novartis Investigative Site, Ho Chi Minh City, Vietnam

מובילי המחקר

  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)